Rocket Pharmaceuticals (RCKT) Proxy filing summary

Voting matters and shareholder proposals

• Election of seven directors to serve until the 2027 annual meeting or until successors are elected.

• Ratification of EisnerAmper LLP as independent auditor for the fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay) is included.

• Approval sought for a proposed stock option exchange program.

• Provision for transaction of any other business that may arise at the meeting.

Board of directors and corporate governance

• Seven nominees are presented for election, including Peter Fong, Carsten Boess, Mikael Dolsten, Fady Malik, Gaurav Shah, David P. Southwell, and Roderick Wong.

Executive compensation and say-on-pay

• Shareholders are asked to provide a non-binding advisory vote on the compensation of named executive officers.

• A stock option exchange program is proposed for approval.